Abstract

Aims To describe the sequence of clinically apparent events causing readmission and antedating death, subsequent to a first-time hospital admission for heart failure, in order to give insights into the natural history and mechanisms of progression of heart failure.

Methods A national database of linked hospital discharge and mortality data for Scotland (population 5·1 million) was used. Patients with a first-time admission to hospital with heart failure in 1992 (index population) were identified and, using a record linkage system, hospital readmissions and their cause according to the hospital physician and deaths were recorded over the subsequent 3 years. A flowchart showing the sequence of events leading to death or recurrent admission was constructed.

Results 12640 patients had first-time admissions with heart failure in 1992; their mean age was 74 years and 46·2% were men. A cohort of 2922 (23%) patients died on their first admission. Among the remaining 9718 patients there were 22747 readmissions and 4877 deaths over the subsequent 3 years; only 15% had neither event reported. Nine per cent of patients died without any readmission and a further 6% without a further readmission for cardiovascular reasons. A cohort of 5992 (61% of patients at risk) had at least one cardiovascular readmission and half of these had occurred within 6 months. Heart failure without a report of any cardiovascular precipitating event was responsible for 37% (2188 patients) of first cardiovascular readmissions and of these patients approximately 12% had evidence of renal failure or acute respiratory infection as possible triggers for readmission. Acute ischaemic events including myocardial infarction (19%), myocardial infarction alone (8%) and atrial fibrillation (11%) were associated with a substantial number of first readmissions. First readmission precipitated by acute myocardial infarction was associated with a particularly poor prognosis (40% inpatient mortality).

Conclusions Recurrent ischaemic events and atrial fibrillation may be the predominant mechanisms leading to exacerbation of and progression of heart failure and death. A substantial proportion of readmissions appear related to heart failure alone. Whether this reflects progressive ventricular remodelling leading to worsening heart failure or other unidentified mechanisms cannot be discerned from this data.

f1
Correspondence: Professor John G.F. Cleland, MD, FRCP, FACC, FESC, Department of Cardiology, Castle Hill Hospital, University of Hull, Kingston-upon-Hull, HU16 5JQ, U.K.

References

1
Mcmurray
J
, Mcdonagh T, Morrison CE, Dargie HJ. Trends in hospitalisation for heart failure in Scotland 1980–1990.
Eur Heart J
 .
1993
;
14
:
1158
–1162
2
Haldemand
GA
, Croft JB, Giles WH, Rashidee A. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995.
Am Heart J
 .
1999
;
137
:
352
–360
3
Reitsma
JB
, Dalstra JAA, Bonsel GJ. Cardiovascular disease in the Netherlands, 1975 to 1995: decline in mortality, but increasing numbers of patients with chronic conditions.
Heart
 .
1999
;
82
:
52
–56
4
Swedberg
K
, Idanpaan Heikkila U, Remes J. Effects of enalapril on mortality in severe congestive heart failure. Results of the Coperative North Scandinavian Enalapril Survival Study (CONSENSUS).
New Eng J Med
 .
1987
;
316
:
1429
–1435
5
Packer
M
, Bristow MR, Cohn JN. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.
New Eng J Med
 .
1996
;
334
:
1349
–1355
6
Lancet
 .
1999
;
353
:
9
–13
7
Ball
SG
, Hall AS, Mackintosh AF. Effect of ramipril and morbidity of surviviors of acute myocardial infarction with clinical evidence of heart failure.
Lancet
 .
1993
;
342
:
821
–828
8
Cleland
JGF
, Gemmel I, Khand AU, Boddy A. Is the prognosis of heart failure improving?
Eur J Heart Failure
 .
1999
;
1
:
229
–241
9
Teerlink
JR
, Pfeffer JM, Pfeffer MA. Effect of left ventricular sphericity on the evolution of ventricular dysfunction in rats with diffuse isoproteronol-induced myocardial necrosis.
J Cardiac Failure
 .
1998
;
4
:
45
–56
10
Torp-Pederson
LKC
, Kober L, Carlsen J. Angio-converting enzyme inhibition after myocardial infarction: the Trandolapril Cardiac Evaluation Study.
Am Heart J
 .
1996
;
132
:
235
–243
11
St. John Sutton
M
, Pfeffer MA, Moye L. Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial.
Circulation
 .
1997
;
96
:
3294
–3299
12
Cohn
JN
, Johnson GR, Ziesche S. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.
N Eng J Med
 .
1991
;
325
:
303
–310
13
Yusuf
S
, Pepine CJ, Garces C. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions.
Lancet
 .
1992
;
340
:
1173
–1178
14
Rutherford
JD
, Pfeffer MA, Moye LA. Effects of captopril on ischaemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial SAVE Investigators.
Circulation
 .
1994
;
90
:
1731
–1738
15
Lonn
EM
, Yusuf S, Montague TJ. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.
Circulation
 .
1994
;
90
:
2056
–2069
16
Cleland
JGF
, Erhardt L, Murray G, Hall AS, Ball SG. Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure.
Eur Heart J
 .
1997
;
18
:
41
–51
17
Ghali
JK
, Kadakia S, Cooper R, Ferlinz J. Precipitating factors leading to decompensation of heart failure. Traits among urban blacks.
Arch Internal Medicine
 .
1988
;
148
:
2013
–2016
18
Krumholz
HM
, Parent EM, Tu N. Early readmission of elderly patients with congestive heart failure.
J Am Geriatr Soc
 .
1990
;
38
:
1290
–1295
19
Cleland
JGF
, Poole-Wilson PA, Packer M. Critical event pathways for progression of heart failure and mortality: Insights from the ATLAS study. [Abstr].
J Am Coll Cardiol
 .
1999
;
33
:
1228
–1228
20
Anonymous. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD investigators.
N Eng J Med
 .
1991
;
325
:
293
–302
21
Remme
WJ
. Prevention of worsening heart failure: future focus.
Eur Heart J
 .
1998
;
19
:
47
–53
22
Patten
RD
, Udelson JE, Konstam MA. Ventricular remodeling and its prevention in the treatment of heart failure.
Curr Opin Cardiol
 .
1998
;
13
:
162
–167
23
Lechat
P
. Prevention of heart failure progression: current approaches.
Eur Heart J
 .
1998
;
19
:
B12
–18
24
Cowie
MR
, Wood DA, Coats AJS. Incidence and aetiology of heart failure, A population-based study.
Eur Heart J
 .
1999
;
20
:
421
–428
25
Kendrick
S
, Clarke J. The Scottish Record Linkage System.
Health Bull
 .
1993
;
51
:
72
–79
26
Harley
K
, Jones C. Quality of Scottish Morbidity Record (SMR) Data.
Health Bull
 .
1996
;
54
:
410
–417
27
Anonymous. The West of Scotland Coronary Prevention Group: Computerised record linkage compared with traditional patients follow-up methods in clinical trials and illustrated in a prospective epidemiological study.
J Clin Epidemiology
 .
1995
;
48
:
1441
–1452
28
Opasich
C
, Febo O, Riccardi PG. Concomitant factors of decompensation in chronic heart failure.
American Journal of Cardiology
 .
1996
;
78
:
354
–357
29
Krumholz
HM
, Parent EM, Tu N. Readmission after hospitalization for congestive heart failure among medicare beneficiaries.
Arch Intern Med
 .
1997
;
157
:
99
–104
30
Gooding
J
, Hette AM. Hospital readmissions among the elderly.
J Am Geriatr Soc
 .
1990
;
33
:
595
–601
31
Feenstra
J
, Grobbee DE, Jonkman FAM, Hoes AW, Stricker BHC. Prevention of relapse in patients with congestive heart failure: the role of precipitating factors.
Heart
 .
1998
;
80
:
432
–436
32
Registrar General, Annual Report of the Registrar General For Scotland, 1992, The Scottish Office, Edinburgh, Scotland
33
Van Den Berg
MP
, Tuinenberg AE, Crijns HJGM. Heart failure and atrial fibrillation: current concepts and controversies.
Heart
 .
1997
;
77
:
309
–313
34
Cowburn
PJ
, Cleland JGF, Coats AJS, Komajda M. Risk stratification in chronic heart failure.
Eur Heart J
 .
1998
;
19
:
696
–710
35
Khand
AU
, Rankin AC, Kaye G, Cleland JGF. Systematic review of the management of atrial fibrillation in patients with heart failure.
Eur Heart J
 .
2000
;
21
:
614
–632
36
Ho
KK
, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study.
J Am Coll Cardiol
 .
1993
;
22
:
6A
–13A
37
Cowie
MR
, Mosterd A, Wood DA. The epidemiology of heart failure.
Eur Heart J
 .
1997
;
18
:
208
–215
38
Kohli
HS
, Knil-Jones RP. How accurate are SMR 1 (Scottish Morbidity Record 1).
Data. Health Bull
 .
1992
;
50
:
14
–23
39
Patel
AR
, Gray G, Lang GD, Baillie FGH, Fleming L, Wilson GM. Errors in diagnostic returns.
Health Bull
 .
1976
;
34
:
215
–220
40
Murdoch
DR
, Love MP, Robb SD. Importance of heart failure as a cause of death. Changing contribution to overall mortality and coronary heart disease mortality in Scotland 1979–1992.
Eur Heart J
 .
1998
;
19
:
1829
–1835
41
Lauer
MS
, Blackstone EH, Young J, Topol EJ. Cause of Death in Clinical Research.
J Am Coll Cardiol
 .
1999
;
34
:
618
–620
42
Narang
R
, Cleland JGF, Erhardt L. Mode of death in chronic heart failure: a request for more accurate classification.
Eur Heart J
 .
1996
;
17
:
1390
–1403
43
Cleland
JGF
, Massie BM, Packer M. Sudden Death in Heart Failure: vascular or electrical?
Eur J Heart Fail
 .
1999
;
1
:
41
–45
44
Uretsky
B
, Armstrong PW, Cleland JGF. Ischaemia as a 'trigger' for sudden death in patients with cardiomyopathy and heart failure secondary to coronary artery disease: results from the ATLAS trial [Abstr].
Circulation
 .
1998
;
199
:
45
Morooka
S
, Hayashi T, Takayanagi K, Inoue T, Sakai Y, Takabatake Y. Heart Failure progression due to secondary organ dysfunction in acute heart failure.
Japan Heart J
 .
1995
;
36
:
29
–36
46
Okaishi
K
, Morimoto S, Fukuo K. Reduction of Risk of Pneumonia Associated with use of Angiotensin I Converting Enzyme Inhibitors in elderly Inpatients.
Am J Hypertension
 .
1999
;
99
:
778
–783
47
Wikstrom
G
, Malmberg K, Ryden L. Improved knowledge of antidiabetic treatment—a necessity for the modern cardiologist.
Eur Heart J
 .
1999
;
20
:
403
–405
48
Michalsen
A
, Konig G, Thimme W. Preventable causative factors leading to hospital admission with decompensated heart failure.
Heart
 .
1998
;
80
:
437
–441
49
Vinson
JM
, Rich MW, Sperry JC. Early readmission of elderly patients with congestive heart failure.
J Am Geriatr Soc
 .
1990
;
38
:
1290
–1295
50
Pedersen
OD
, Bagger H, Torp-Pederson LKC. Trandolapril reduces incidence of atrial fibrillation following acute myocardial infarction.
Circulation
 .
1999
;
100
:
376
–380
51
Anonymous. Effects of carvedilol, a vasodilator beta-blocker, in patients with congestive heart failure due to ischaemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
Circulation
 .
1995
;
92
:
212
–218
52
Anonymous. Randomised trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction: ISIS-1. First international study of Infarct survival collaborative group.
Lancet
 .
1986
;
ii
:
57
–66
53
Pitt
B
, Zannad F, Remme WJ. The effects of spironolactone on morbidity and mortality in patients with severe heart failure.
N Eng J Med
 .
1999
;
341
:
709
–717
54
Pedersen
OD
. Dofetilide in the treatment of atrial fibrillation in patients with impaired left ventricular function: Atrial Fibrillation in the DIAMOND study [Abstract].
Circulation
 .
1998
;
98
:
I-632
55
Cappuci
A
, Aschieri GQ, Villani F, Passerini F, Groppi A. Oral amiodarone increases efficacy of DC cardioversion in patients with chronic atrial fibrillation and organic heart disease.
J Am Coll Cardiol
 .
1997
;
29
:
443A
56
Chapman
MJ
, Moran JL, O'Fathartaigh MS, Peisach AR, Cunningham DN. Management of atrial tachyarrhythmias in the critically ill: a comparison of intravenous procainamide and amiodarone.
Intensive Care Medicine
 .
1993
;
19
:
48
–52
57
Deedwania
PC
, Singh BN, Ellenbogen KA, Fisher S, Fletcher R, Singh SN. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation.
Circulation
 .
1998
;
98
:
2574
–2579
58
Eur J Heart Fail
 .
1999
;
1
:
95
–99

Comments

0 Comments